AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Archives: News
Five AI Healthcare Startups Bringing Us Closer to Cures
Clinical Informatics tells us that: “Every year in the U.S., approximately 2 million patients participate in roughly 3000 clinical trials; six million patients are needed to meet U.S. recruitment goals. Consequently, up to 90% of trials are delayed or over budget”. Experts blame the lack of data available – to both patients and researchers – …
Five AI Healthcare Startups Bringing Us Closer to Cures Read More »
Innoplexus Brings Blockchain to Pharma
Global AI firm Innoplexus launched an innovative blockchain platform to dramatically raise the amount of data available for drug research and discovery. This new platform, an update to Innoplexus’ flagship product iPlexus is the first of its kind and will enable researchers to upload and license unpublished data on the blockchain to facilitate collaboration, reduce …
Founder fights cancer with artificial intelligence
Gunjan Bhardwaj helps pharmaceutical companies to find out more about diseases. By harnessing artificial intelligence, pharmaceutical companies are able to develop drugs more quickly. Frankfurt. It was a life-changing experience for Gunjan Bhardwaj to have a dear friend diagnosed with cancer years ago. In a desperate attempt to help, Bhardwaj, an Indian-born businessman, scavenged the …
Founder fights cancer with artificial intelligence Read More »
AI-based drug development to broaden gap between pharmaceuticals
Local pharmaceutical firms should brace for a new era where drugmakers take advantage of artificial intelligence (AI) to develop a new medicine, experts said. The AI-using new drug development has already become the latest trend and doing so will save cost and time, they said at a news conference at the AI Pharma Korea Conference …
AI-based drug development to broaden gap between pharmaceuticals Read More »
Google for Pharma
Indian and Swabian Together with friends from India, Gunjan Bhardwaj has successfully launched Innoplexus, a sophisticated ecosystem of continuous analytics, powered by artificial intelligence and machine learning.The goal: Innoplexus wants to become the European champion for AI. The chances: excellent. At 35, Gunjan Bhardwaj was an aspiring management consultant at Ernst & Young. The atmosphere …
We want to democratize data
Dr. Gunjan Bhardwaj is the founder and CEO of Innoplexus AG. With the help of artificial intelligence, blockchain and big data analysis applications, its iPlexus software has crawled over 300 terabytes of relevant clinical and medical data and put them in a logical context, being constantly updated and delivered to the workstations of customers in …
How artificial intelligence impacts preventative care
With a dramatic rise in physician burnout and many physicians exiting the field prematurely, the health care industry is looking to artificial intelligence (AI) to provide much needed support. AI can impact physicians’ workloads through treatment plan designs and repetitive jobs assistance to data mining through millions of medical records. AI has already entered the …
How artificial intelligence impacts preventative care Read More »
More transparency would bolster big pharma’s image
It’s no surprise that the public hates Big Pharma. They rank just under the government on most Americans’ despised institution list.
Innoplexus is working on solutions in response to GDPR and other data privacy restrictions
Innoplexus is at the forefront of decision-making technology as the company works in data aggregation to provide to